VivoSeq
Other

Progesterone

0

Pipeline Programs↗

11

Active Trials↗

4

Companies Involved↗

Progesterone is an early-stage landscape with 0 programs across 4 companies. The most active players are Ferring, Teva, HRA Pharma.

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ferring logo

Ferring

0 programs

PreclinicalTeva logo

Teva

0 programs

PreclinicalH

HRA Pharma

0 programs

PreclinicalA

Arno Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

112

clinical trials

Completed65 · 58%
Unknown status17 · 15%
Terminated11 · 10%
Withdrawn8 · 7%
Not yet recruiting6 · 5%
Recruiting4 · 4%
Other1 · 1%

Clinical Trials

Trial Activity

112 trials

Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS
Recruiting·—·N/A·NCT07242131·150 enrolled
Progesterone as Luteal Support in Frozen IVF Natural Cycles
Recruiting·—·Phase 4·NCT04725864·1,800 enrolled
Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies
Recruiting·MMỹ Đức Hospital·N/A·NCT06463652·328 enrolled
Role of Low Dose Injectable Progesterone in Triggering Ovulation
Recruiting·—·N/A·NCT06928844·120 enrolled
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
Active, not recruiting·IIBSA Institut Biochimique SA·Phase 3·NCT04549116·680 enrolled
Effect of Progesterone Administration on Severely Head Injured Patients
Not yet recruiting·—·Phase 1·NCT06631547·50 enrolled
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Not yet recruiting·DDaré Bioscience, Inc.·Phase 1·NCT06668896·60 enrolled
Exogenous Progesterone as Ovulation Trigger
Not yet recruiting·IInstituto Valenciano de Infertilidade de Lisboa·Phase 4·NCT07466199·10 enrolled
Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix
Not yet recruiting·NNational Hospital of Obstetrics and Gynecology·N/A·NCT07372495·260 enrolled
Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles.
Not yet recruiting·TTrust Fertility Clinic·Phase 4·NCT07350317·230 enrolled
Progesterone-modified Natural Cycle for FET
Not yet recruiting·SShandong University of Traditional Chinese Medicine·Phase 3·NCT06644794·336 enrolled
Progesterone Action on Endometrium of PCOS
Completed·UUniversity of Sao Paulo General Hospital·N/A·NCT05062135·36 enrolled
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
Completed·Teva logoTeva·Phase 1·NCT02817464·12 enrolled
Step Down FSH Approach and Late Follicular Phase in Progesterone Level
Completed·AART Fertility Clinics LLC·Phase 1·NCT03356964·127 enrolled
Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
Completed·—·N/A·NCT07264933·750 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)